Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/10/ge-healthcare-jumps-6-after-earnings-beat-and-outlook-rises.webp

GE HealthCare Jumps 6% After Earnings Beat and Outlook Rises

TIM BOHEN•UPDATED OCT. 28, 2026, 7:38 AM ET
Reviewed by Ben Sturgilland Fact-checked by Jeff Zananiri

GE HealthCare is up 6% before regular trading opens after beating quarterly estimates and raising its full-year profit outlook.

GEHC Candlestick Chart

Get Free Alerts

Why GE HealthCare Rose 6% Before Markets Opened

GE HealthCare Technologies Inc. (NASDAQ: GEHC) is up 6% in premarket trading, before regular market hours, at $75.72, after closing at $71.11, and reached $76.19 in premarket. Third-quarter adjusted earnings per share, which measures profit for each share after excluding specified items, and revenue both beat analyst estimates. The higher full-year forecast signals management expects more adjusted profit this year, helping explain the gain.

What GE HealthCare Technologies Inc. Does

GE HealthCare makes medical imaging and ultrasound systems used in clinical care. Hospitals and clinics use these tools to help diagnose and monitor patients, so customer demand can affect the company’s sales.

GE HealthCare Raises Its Full-Year Earnings Outlook

GE HealthCare reported adjusted earnings per share of $1.34 and revenue of $5.5 billion; both topped analyst estimates. It lifted its full-year adjusted earnings-per-share outlook to $4.95 to $5.05 from $4.80 to $5.00. The higher range raises the profit management expects for the year, but does not give a separate next-quarter forecast.

Quick Financial Overview

GE HealthCare is a profitable large-cap, meaning it has a large total stock-market value. Its market cap, the value of its publicly traded shares, is $34.20B. It held $2.08B in cash and cash equivalents, meaning cash the company can spend, as of June 30, 2026.

GE HealthCare Generates Cash From Operations

The business generated $907 million in cash from operations, meaning money brought in through its day-to-day activities during the quarter. Free cash flow was $793 million, meaning cash left after spending on equipment and other long-term assets. That leaves money for uses beyond running and maintaining the business.

GE HealthCare Orders and Backlog

Its backlog was $23.7 billion, meaning customer orders the company has not yet filled. The book-to-bill ratio was 1.03 times, meaning new orders were slightly above sales billed. That can point to future work, though GE HealthCare still has to deliver those orders.

Get Free Alerts

GE HealthCare’s One-Month Return Is +6.54%

The one-month return for GE HealthCare is +6.54%, and shares now trade above the prior-month high before the regular session opens. This extends the recent climb, but the chart alone cannot show whether business growth will continue. For GE HealthCare, the last daily move this large was sixty-four sessions ago.

Get Free Alerts

Conclusion

The next quarterly earnings report will test how much of GE HealthCare’s unfilled work becomes completed business, though its date is not available. Faster deliveries would turn those orders into cash sooner, while delays would leave more customer commitments waiting to become sales.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders